🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

However, doctors and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Several experts said the popularity for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and consumer laws, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Removal

According to TikTok, the platform has removed problematic content and prohibited related hashtags and query recommendations. The company said it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Online Trading Operations

Research also discovered groups with up to nine thousand members marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, populated with photos of slimming results, glowing testimonials and detailed instructions for mixing or administering at residence.

After minutes of joining one community, a seller posted WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Details and Costs

Within these groups, messages display black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A representative for Telegram said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Although the science behind this drug is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has previously encountered patients harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious health risks”.